Pitcairn’s Pediatrix Medical MD Stock Holding History

Pitcairn’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-6,014	Closed	-$417K	–	492
2017 Q1	$417K	Sell	6,014 -75	-1%	-$5.21K	0.05%	283
2016 Q4	$406K	Sell	6,089 -320	-5%	-$20.8K	0.05%	300
2016 Q3	$425K	Sell	6,409 -115	-2%	-$7.87K	0.05%	281
2016 Q2	$472K	Buy	6,524 +1,617	+33%	+$111K	0.06%	238
2016 Q1	$317K	Sell	4,907 -1,453	-23%	-$96.4K	0.04%	329
2015 Q4	$456K	Buy	6,360 +168	+3%	+$12.4K	0.05%	256
2015 Q3	$475K	Sell	6,192 -13,579	-69%	-$1.1M	0.06%	240
2015 Q2	$1.47M	Sell	19,771 -1,508	-7%	-$109K	0.17%	110
2015 Q1	$1.54M	Sell	21,279 -87	-0.4%	-$6.05K	0.17%	106
2014 Q4	$1.41M	Buy	21,366 +2,225	+12%	+$136K	0.15%	115
2014 Q3	$1.05M	Sell	19,141 -342	-2%	-$19.4K	0.12%	145
2014 Q2	$1.13M	Sell	19,483 -1,857	-9%	-$109K	0.13%	137
2014 Q1	$1.32M	Buy	+21,340	New	+$1.24M	0.15%	117

Other funds holding MD

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Pitcairn's MD Position: Q2 2017 in Review

Pitcairn sold out of Pediatrix Medical (MD) in Q2 2017, closing a stake of 6,014 shares — an estimated $417K sold.

Pitcairn first reported a position in MD in Q1 2014 and held it in 13 quarters. The position peaked at $1.54M in Q1 2015. 332 funds tracked by Wall St. Rank hold MD as of Q2 2017.

Pitcairn reported no remaining Pediatrix Medical position as of Q2 2017 after selling out during the quarter.
Pitcairn sold 6,014 Pediatrix Medical shares in Q2 2017, an estimated $417K.
Pitcairn first reported a position in Pediatrix Medical in Q1 2014 and held it in 13 quarters.
Pitcairn's Pediatrix Medical position peaked at $1.54M in Q1 2015.
332 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2017.

Based on Pitcairn's 13F filing for Q2 2017, filed 2 Aug 2017.